Edgewise Therapeutics, Inc. EWTX Deferred Offering Costs Included In Accounts Payable And Accrued Other Expenses
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept ewtx:DeferredOfferingCostsIncludedInAccountsPayableAndAccruedOtherExpenses.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s deferred offering costs included in accounts payable and accrued other expenses?
- Edgewise Therapeutics, Inc. (EWTX) reported deferred offering costs included in accounts payable and accrued other expenses of $395K in Q1 2025.